Olanzapina Farmoz (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Farmoz, is an atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Olanzapina Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapina Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine is an atypical antipsychotic that modulates neurotransmission in several psychiatric disorders.

- Schizophrenia: helps control hallucinations, delusions and thought disorder. - Bipolar I disorder (manic episodes): reduces mania severity and stabilises mood. - Bipolar I disorder (depressive episodes): alleviates depressive symptoms as part of maintenance therapy. - Schizoaffective disorder: improves both psychotic and mood components. - Psychotic depression: augments antidepressant response in major depressive disorder with psychotic features.

Olanzapine may cause a range of adverse reactions, from mild to potentially serious.

Common Side Effects: - Weight gain: increased appetite and caloric intake. - Sedation: drowsiness or feeling of being overly relaxed. - Dry mouth: reduced salivary flow. - Constipation: slowed gastrointestinal motility. - Elevated triglycerides: rise in blood lipid levels. - Orthostatic hypotension: drop in blood pressure upon standing.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Tardive dyskinesia: involuntary, repetitive facial movements. - Hyperglycaemia: significant rise in blood glucose, possibly leading to diabetes. - Seizures: occurrence of convulsive episodes. - Agranulocytosis: marked reduction of the blood cell white blood cell white white white white white white white white white white white white white white white white white white white white white white white white white white white white white white white white ...

Olanzapine should be used with careful clinical monitoring.

- Monitor: regular assessment of weight, fasting glucose, and lipid profile. - Caution: patients with a history of cardiovascular risk or orthostatic hypotension may be … -   … ... ...  … … ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... … ... ... … ... ... ... ... ... ... ... ... ... ... ... … … … … … ... ... ... ... ......… … ... … ... ... ...